Loading…
Loading…
EQUITY / NASDAQ · XNCM
iSpecimen Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.08 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 1.08 USD · Volume 148,778
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 151,940 USD | 713,135 USD | -78.69% |
| Operating profit | -1,362,986 USD | -1,821,426 USD | — |
| Net income | -1,362,811 USD | -1,047,243 USD | — |
| Cash and cash equivalents | 4,414,364 USD | — | — |
| Total liabilities | 5,656,821 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 4,414,364 USD | — | — | — | 6,880,835 USD | — | — | — |
| Net incomeIncome statement | -1,362,811 USD | -3,638,032 USD | -2,275,221 USD | — | -10,487,532 USD | -2,780,648 USD | -5,486,287 USD | -1,047,243 USD |
| Operating profitIncome statement | -1,362,986 USD | -3,901,388 USD | — | — | -8,977,919 USD | -2,830,222 USD | -6,290,037 USD | -1,821,426 USD |
| RevenueIncome statement | 151,940 USD | 307,949 USD | — | — | 1,928,998 USD | 106,592 USD | 1,877,237 USD | 713,135 USD |
| Total assetsBalance sheet | 7,393,201 USD | — | — | 9,531,410 USD | 9,531,410 USD | 8,997,557 USD | — | — |
| Total equityBalance sheet | 1,736,380 USD | — | 814,038 USD | 3,088,231 USD | 3,088,231 USD | 3,072,711 USD | — | 621,973 USD |
| Total liabilitiesBalance sheet | 5,656,821 USD | — | — | 6,443,179 USD | 6,443,179 USD | 5,924,846 USD | — | — |
| Financing cash flowCash flow statement | — | 2,285,000 USD | — | — | 10,243,489 USD | — | 5,228,489 USD | — |
| Investing cash flowCash flow statement | — | -700,000 USD | — | — | -1,000,454 USD | — | -1,000,454 USD | — |
| Operating cash flowCash flow statement | — | -4,051,471 USD | — | — | -4,240,608 USD | — | -3,323,685 USD | — |
| Capital expendituresCash flow statement | — | — | — | — | 454 USD | — | 454 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 04/01/2026 | Open report ↗ Published: 11/17/2025 | Open report ↗ Published: 11/17/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.